Moderna (NSDQ:MRNA) shares took a big hit today on third-quarter results that came up short of the consensus forecast.
MRNA shares were down 17.1% at $286.80 per share in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 0.2%.
Get the full story at our sister site, Pharmaceutical Processing World.
Filed Under: Drug Discovery, Drug Discovery and Development, Infectious Disease
Tell Us What You Think!
You must be logged in to post a comment.